Injectable, flexible electrode could replace rigid nerve-stimulating implants

November 11, 2019

MADISON, Wis. -- By electrically stimulating nerves, neuromodulation therapies can reduce epileptic seizures, soothe chronic pain, and treat depression and a host of other health conditions without the use of conventional drugs like opioids.

Now, University of Wisconsin-Madison biomedical engineers and their collaborators have made a significant advance that could dramatically reduce the cost of neuromodulation therapy, increase its reliability and make it much less invasive.

With a type of electrode that can be injected as a liquid and then cure in the body, the researchers have laid the groundwork for a new kind of neural interface system.

The researchers unveiled their creation, which they've dubbed the "injectrode," in a paper published online this week in the journal Advanced Healthcare Materials.

Today's neuromodulation treatments rely on surgically implanted devices that can cost up to six figures, require complex procedures to install, and often fail -- given that they're rigid devices attempting to mesh with soft biological tissue.

The researchers' system leverages an entirely new way of thinking.

"You can inject the liquid around the nerve, and it cures in the body to create a wired contact," says Kip Ludwig, a UW-Madison professor of biomedical engineering and neurological surgery. "Typical implants are really stiff, and so as the body moves, they wear and tear and break down. Our liquid cures, and the result is much closer to the normal elasticity of tissue. You can actually stretch it and increase its size 150 percent to 200 percent without losing its conductivity."

To create the injectrode, the researchers mixed a silicone base -- similar to surgical glue -- with small metal particles to make the liquid sufficiently conductive.

They put their device through a battery of Food and Drug Administration preclinical tests, and used it to induce heart rate changes in pigs by stimulating their vagus nerve, an approach that's shown promise for treating heart failure, hypertension and other maladies.

"We essentially went through the standard repertoire of electrochemical tests to show this acts like a standard wire electrode that could be used to stimulate the nerve," says James Trevathan, a postdoctoral fellow in Ludwig's lab and first author on the study.

Ludwig co-authored the study and cofounded Neuronoff, a company based on the injectrode, with Case Western Reserve University biomedical engineering professor Andrew Shoffstall and Neuronoff CEO Manfred Franke. They're also part of a multi-institution team that recently secured a $2.1 million grant from the National Institutes of Health to further develop the system to stimulate spinal nerves as a non-opioid alternative to treating chronic back pain.

The paper and grant represent crucial early steps in a larger effort to create a minimally invasive system for neural stimulation.

As part of the NIH grant, the researchers are testing a scheme in which they inject the fluid around the nerve, then extrude a thin insulated string of the material back to just underneath the surface of the skin, where they inject more of the composite material. Then they can use a basic transcutaneous electrical nerve stimulation, or TENS, unit -- the kind you can buy at a department store or pharmacy -- to stimulate the nerve from the surface of the skin, making the whole setup less expensive and more adaptable compared to traditional implanted electrodes.

"We're making a bypass from the surface of the skin to the location we want to stimulate," says Ludwig, who envisions eventually using a robotic surgical system for a procedure that would be akin to getting a tattoo. "As we learn more and more about how to interface with the nervous system, we're not limited to what we've implanted through an invasive surgical procedure. We can actually change how we stimulate, how we talk to the nerve, because we're essentially just routing our connection to this deep nerve back to the surface of the skin."
Other coauthors on the paper include Professor Justin Williams and senior scientist Aaron Suminski of the UW-Madison Department of Biomedical Engineering, Doug Weber of the University of Pittsburgh, and researchers from Mayo Clinic.

This research was supported by the Defense Advanced Research Projects Agency (grant N66001?17?2?4010), National Science Foundation (DMR?1720415) and NIH (1U18EB029251?01).

--Tom Ziemer, 608-265-8669,


University of Wisconsin-Madison

Related Biomedical Engineering Articles from Brightsurf:

Applying machine learning to biomedical science
Dr Pengyi Yang and colleagues from the University of Sydney have brought together the latest developments in applications of machine learning in biomedical science, showing that new techniques are combining ensemble methods with deep learning, with potential applications in cancer research and better understanding viruses.

Hydrogel paves way for biomedical breakthrough
Dubbed the ''invisibility cloak'', engineers at the University of Sydney have developed a hydrogel that allows implants and transplants to better and more safetly interact with surrounding tissue.

Biomedical instrument based on microvesicles
Researchers have proved that a microvesicle-based instrument can be effective in reducing inflammation and immune response.

Biomedical researchers get closer to why eczema happens
A new study from researchers at Binghamton University, State University of New York may help to peel back the layers of unhealthy skin -- at least metaphorically speaking -- and get closer to a cure.

Artificial intelligence improves biomedical imaging
ETH researchers use artificial intelligence to improve quality of images recorded by a relatively new biomedical imaging method.

Transparency and reproducibility of biomedical research is improving
New research publishing Nov. 20 in the open-access journal PLOS Biology from Joshua Wallach, Kevin Boyack, and John Ioannidis suggests that progress has been made in key areas of research transparency and reproducibility.

A pill for delivering biomedical micromotors
Using tiny micromotors to diagnose and treat disease in the human body could soon be a reality.

Accounting for sex differences in biomedical research
When it comes to health, a person's sex can play a role.

Biomedical Engineering hosts national conference on STEM education for underserved students
The University of Akron hosts a national conference aimed at ensuring underserved students have access to opportunities in science, technology, engineering and mathematics (STEM).

Boosting the lifetime and effectiveness of biomedical devices
A research team led by the University of Delaware's David Martin has discovered a new approach to boosting the lifetime and effectiveness of electronic biomedical devices.

Read More: Biomedical Engineering News and Biomedical Engineering Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to